All In MedTech

510(k) device

CoaguChek Vantus System

Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA decisions

1

510(k) pathway

Device trials

0

Naming "CoaguChek Vantus"

MAUDE reports

35

Brand "CoaguChek Vantus", since 2015

PubMed studies

0

Mentioning "CoaguChek Vantus"

AI summary across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

Product review deck

A slide deck reviewing CoaguChek Vantus System

About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.

  • Executive summary and key facts
  • Technology
  • Clinical evidence and trials
  • Regulatory history and safety
  • Reimbursement, market and competition
  • Risks, outlook and sources

AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.

FDA decisions

The newest 1 of 1 decisions filed under this name.

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

Clinical trials

Device studies on ClinicalTrials.gov that name "CoaguChek Vantus", any status and sponsor, newest update first.

Open in Trial Radar

No registered device study names "CoaguChek Vantus".

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "CoaguChek Vantus", and for the whole product code for context.

This brand

35 reports: 29 malfunction, 6 injury, 0 death

Whole product code GJS

12,207 reports: 11,507 malfunction, 644 injury, 34 death

Newest reports for this brand

  • ROCHE DIAGNOSTICS

    1823260-2025-02901 · Received Sep 16, 2025 · Event dated Aug 12, 2025

    Device type: Test, Time, Prothrombin (GJS)

    Device problem as coded: Device Difficult to Setup or Prepare; High Test Results; Adverse Event Without Identified Device or Use Problem

    Patient problem as coded: Headache; Nausea; Dizziness

  • COAGUCHEK VANTUSMalfunction

    ROCHE DIAGNOSTICS

    1823260-2023-04159 · Received Dec 21, 2023 · Event dated Dec 6, 2023

    Device type: Test, Time, Prothrombin (GJS)

    Device problem as coded: Image Display Error/Artifact

    Patient problem as coded: No Clinical Signs, Symptoms or Conditions

  • ROCHE DIAGNOSTICS

    1823260-2023-03792 · Received Nov 29, 2023 · Event dated Oct 20, 2023

    Device type: Test, Time, Prothrombin (GJS)

    Device problem as coded: Circuit Failure; No Device Output; High Test Results; Adverse Event Without Identified Device or Use Problem

    Patient problem as coded: Easy Bruising

2 more reports with a free account

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

Published research

The most relevant PubMed records for "CoaguChek Vantus"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

No PubMed record mentions this device by name.

Other devices of this type

Also filed under product code GJS.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.